Shorter courses of more intense radiation therapy mean fewer visits and less cost for patients. Studies show abbreviated treatments are just as effective as longer courses.

by Stephen Ornes

With targeted therapy options available for a growing number of cancer types, biomarker testing is making a difference for more people with solid cancers.

by Kendall K. Morgan

Geriatric assessments can help physicians and older patients choose effective treatments with fewer side effects.

by Eric Fitzsimmons

Q&A

Journalist Lawrence Ingrassia traces the scientific history of a genetic disorder that predisposes families like his to cancer.

by Thomas Celona

Forward Look

Androgen deprivation therapy, a common prostate cancer treatment, may increase cognitive difficulties.

by Joseph Jalkiewicz

Chest radiation may not be necessary for people with intermediate-risk breast cancer.

by Thomas Celona

Research finds certain people with low-risk DCIS may be able to forgo surgery or radiation.

by Thomas Celona

Most pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.

by Taneia Surles

Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.

by Sandra Gordon

Study shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.

by Kyle Bagenstose